27
Mon, Mar
28 New Articles

Ferring acquires ex-U.S. assets and rights for Vitaros , Apricus’ on-demand topical cream for erectile dysfunction

Industry Reports
Typography

Ferring Pharmaceuticals announced an agreement with Apricus Biosciences, Inc, granting Ferring global assets and rights, excluding the U.S., related to Apricus’ Vitaros.

Vitaros is an on-demand topical cream indicated for the treatment of patients with erectile dysfunction.Ferring is Apricus’ existing commercialisation partner for Vitaros in Latin America and parts of Europe and Asia. Following an agreed handover period, Ferring will be responsible for managing all Vitaros-related activities outside of the U.S. with existing Vitaros commercialisation partners. Apricus will retain its Vitaros rights in the U.S.

"Urology is a key therapeutic area for Ferring," said Michel Pettigrew, President of the Executive Board and COO, Ferring Pharmaceuticals. “This agreement strengthens our existing portfolio and reinforces Ferring’s commitment to improving the quality of life of patients with a broad range of urological conditions.”

About Ferring Pharmaceuticals
Headquartered in Saint-Prex, Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. For further information on Ferring or its products, visit www.ferring.com. 

*Vitaros® is a registered trademark of NexMed International Limited, and will be assigned to Ferring B.V. worldwide, excluding the United States.  Such trademark is registered in certain countries throughout the world and pending registration in the United States.

For more information:
Ferring Pharmaceuticals
Lindsey Rodger
Tel. +41 58 451 40 23
This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Market Movers

Rogers Corporation Common Stock

NYQ : ROG - 27 Mar, 4:02pm
84.15
+0.67 (+0.80%) After Hours:
Open 82.22 Mktcap 1.52B
High 84.44 52wk Hight 90.45
Low 81.72 52wk Low 51.98
Vol 58434 Avg Vol 104077
Eps 4.44 P/e 31.75
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 27 Mar, 4:00pm
6.14
+0.01 (+0.16%) After Hours:
Open 6.11 Mktcap 89.53B
High 6.15 52wk Hight 6.20
Low 6.09 52wk Low 3.60
Vol 4.73M Avg Vol 5.09M
Eps 0.49 P/e 14.05
Currency: USD

Merck & Company, Inc. Common St

NYQ : MRK - 27 Mar, 4:00pm
63.19
+0.01 (+0.02%) After Hours:
Open 62.92 Mktcap 173.49B
High 63.41 52wk Hight 66.80
Low 62.81 52wk Low 52.44
Vol 8.02M Avg Vol 10.67M
Eps 3.81 P/e 44.82
Currency: USD

Johnson & Johnson Common Stock

NYQ : JNJ - 27 Mar, 4:00pm
125.80
+0.32 (+0.26%) After Hours:
Open 125.16 Mktcap 341.34B
High 126.14 52wk Hight 129.00
Low 125.15 52wk Low 107.69
Vol 5.00M Avg Vol 7.11M
Eps 7.04 P/e 21.21
Currency: USD

Pfizer, Inc. Common Stock

NYQ : PFE - 27 Mar, 4:00pm
34.18
+0.18 (+0.53%) After Hours:
Open 33.74 Mktcap 203.43B
High 34.31 52wk Hight 37.39
Low 33.74 52wk Low 29.41
Vol 17.89M Avg Vol 25.10M
Eps 2.55 P/e 29.14
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 27 Mar, 4:10pm
14.76
-0.11 (-0.77%) After Hours:
Open 14.77 Mktcap
High 14.79 52wk Hight 16.29
Low 14.69 52wk Low 12.60
Vol 4218 Avg Vol 13125
Eps P/e
Currency: USD
Sign up via our free email subscription service to receive notifications when new information is available.
captcha